Micropos Medical AB

Micropos Medical operates in medical technology, and their products are used in radiotherapy. The vision is to develop a technology that improves the precision in radiotherapy, and the product development is based on electromagnetic positioning systems. The product creates real-time information and is mainly used in the treatment of prostate cancer, but also in the treatment of other tumours. The company was established in 2003 and is based in Gothenburg.

Quotes for Micropos Medical AB

Right Now

+/-
%
0,00%
Latest
High
Low
Volume
0
Turnover (SEK)
0
Market Value (MSEK)
291,5
Time (Latest trade)

Board

CEO

  • Richard Forsberg

Chairperson of the Board

  • Ove Mattsson

Board

  • Lena Westergren
  • Olof Sandén
  • Tim Thurn
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    Micropos Medical - Lifesciencedagen

    Micropos Medical Raypilot®

    First RayPilot® patient in UK Edinburgh

    RayPilot® HypoCath™ - A new member of the RayPilot® family

    Largest Owners

    Name Capital % Votes % Date
    Ove Mattsson 28,16 28,16 2024-11-04
    Futur Pension 12,78 12,78 2024-12-23
    Hans Sköld 4,46 4,46 2024-12-23
    Avanza Pension 4,23 4,23 2024-12-23
    Mads Myrtue Thomsen 4,16 4,16 2024-12-23
    Lena Westergren 3,49 3,49 2024-04-02
    Nordnet Pensionsförsäkring 2,65 2,65 2024-12-23
    Anders Walldov 1,65 1,65 2024-12-23
    Gunnar Krantz 1,42 1,42 2024-12-23
    Bernt Magnusson 1,40 1,40 2024-12-23
    ** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

    Insider trading

    *Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

    Key Numbers

    *Compiled data from Millistream

    Upcoming reports

    • 2025-05-21 Årsstämma 2024

    • 2025-05-21 Delårsrapport 2025-Q1

    • 2025-07-31 Delårsrapport 2025-Q2

    • 2025-10-31 Delårsrapport 2025-Q3

    • 2026-01-30 Bokslutskommuniké 2025

    Annual reports, prospectus etc.